Quarterly report pursuant to Section 13 or 15(d)

STOCK OPTIONS AND WARRANTS (Details Narrative)

v3.23.3
STOCK OPTIONS AND WARRANTS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Sep. 06, 2023
Apr. 04, 2023
Jun. 08, 2022
May 05, 2022
Sep. 09, 2021
Aug. 29, 2023
Mar. 29, 2023
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Stock price               $ 1.75   $ 1.75  
Warrant exercise price   $ 4.00         $ 4.00        
Warrant issued to purchaed common stock   174,409         171,296        
Stock compensation expense               $ 16,205 $ 23,326 $ 48,232 $ 91,703
Stock compensation expense unamortized                   $ 6,184  
Weighted average remaining life                   8 months  
Purchase of common stock, shares   174,409 48,309                
Purchase of common stock, value   $ 300,000                  
Interest expense     $ 86,821         $ 36,883 $ 13,624 $ 90,412 $ 127,226
Common stock, par value   $ 0.001                  
Purchase price, per share   $ 1.72                  
Plan termination term   3 months         3 months        
Common share issued                   517,001  
Number of stock option shares, vested                   25,719  
Consultant [Member]                      
Number of stock option shares, vested                   25,719  
Stock option                   $ 41,145  
Warrant [Member]                      
Number of stock option shares, vested                   817,001  
DeCsepel 2022 Subscription Agreement | Warrant [Member]                      
Purchase of common stock, shares       165,929              
Common stock, par value       $ 0.001              
Aggregate warrant amount       $ 250,000              
Purchase price, per share       $ 2.26              
Common stock shares issued       110,619              
Exercise price       $ 6.00              
Plan termination term       3 months              
2014 Equity Incentive Plan [Member]                      
Common stock shares issued                   290,879  
Number of stock option shares, vested                   145,000  
Option grantable               145,879   145,879  
Percent of issued and outstanding shares                   20.00%  
2016 Equity Incentive Plan [Member]                      
Common stock shares issued                   656,250  
Number of stock option shares, vested                   330,350  
Option grantable               325,900   325,900  
2018 Equity Incentive Plan [Member]                      
Common stock shares issued                   450,000  
Number of stock option shares, vested                   380,008  
Option grantable               69,992   69,992  
2022 Equity Incentive Plan [Member]                      
Common stock shares issued                   695,000  
Number of stock option shares, vested                   68,049  
Option grantable               626,951   626,951  
Louis C Lucido [Member]                      
Warrant exercise price           $ 2.00          
Unsecured promissory note payable           $ 150,000          
Interest rate           8.00%          
Conversion price           $ 2.00          
Debt discount $ 88,820         $ 87,724          
Kent Emry [Member]                      
Purchase of common stock, shares     119,617                
Interest expense     $ 214,975         $ 31,507   $ 93,493  
Interest rate         25.00%            
Galligan [Member]                      
Warrant exercise price             $ 4.00        
Warrant issued to purchaed common stock             171,296        
Plan termination term             3 months        
One third party [Member]                      
Warrant exercise price $ 2.00                    
Unsecured promissory note payable $ 150,000                    
Interest rate 8.00%                    
Conversion price $ 2.00                    
Debt discount $ 88,820                    
Common share issued 18,000                    
Common share issued, value $ 30,240                    
Warrants to purchase share 150,000